Life Sciences
The deal is expected to close by the end of 2021.
HIMSS21
Naomi Fried, founder and CEO of PharmStars, discusses how her company mentors digital health startups and coaches pharma executives to prepare both parties for successful partnerships.
The partnership expands on the companies’ earlier collaboration announced in late 2019.
Today at HLTH, panelists discussed how digital is changing the medication delivery space and who will pay for the services.
The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.
IntelliSite is designed to streamline workflows, enhance diagnostic confidence, facilitate collaboration, integrate AI and increase the efficiency of pathology labs.
Sprinter sends nurses and phlebotomists into the home to collect for lab tests, do vitals checks and test for COVID-19.
The SoftVue system is intended to be used in addition to digital mammograms to screen for cancer among patients with dense breast tissue.
As physician workloads in increase, technology is helping providers efficiently connect with pharma reps.
Also: Decentralized clinical trial platform Lightship raises $40 million, and digital pediatric clinic Brave Care scooped up $25 million.